SCHEMBL845008

SCHEMBL845008

Cc1ccccc1C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ccccc3C)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
CYP2C9 P11712 2/20 0.54
CYP2C19 P33261 1/20 0.54
POLB P06746 1/20 0.53
CYP1A2 P05177 1/20 0.52
MAPT P10636 1/20 0.51
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
NPSR1 Q6W5P4 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
MAPK1 P28482 2/20 0.49
TSHR P16473 1/20 0.49
HTT P42858 1/20 0.49
LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL844996 0.90 CYP2C9 (0.50) ALDH1A1CYP2C9CYP2C19KMT2AMEN1
SCHEMBL845350 0.88 MAPK1 (0.49) ALDH1A1CYP2C9CYP2C19CYP1A2MAPK1
SCHEMBL845131 0.88 PABPC1 (0.49) ALDH1A1CYP2C9CYP2C19KMT2AMEN1
SCHEMBL845007 0.88 PABPC1 (0.49) ALDH1A1CYP2C9CYP2C19KMT2AMEN1
SCHEMBL845443 0.88 CYP2C9 (0.47) ALDH1A1CYP2C9CYP2C19MAPTMAPK1
SCHEMBL845257 0.88 TRPV1 (0.48) ALDH1A1CYP2C9CYP2C19MAPTKMT2A
SCHEMBL845284 0.87 MAPK1 (0.58) ALDH1A1CYP2C9CYP2C19KMT2AMEN1
SCHEMBL845016 0.87 CYP2C9 (0.47) ALDH1A1CYP2C9CYP2C19MAPTKMT2A
SCHEMBL845285 0.87 GAA (0.48) ALDH1A1CYP2C9CYP2C19MAPK1HTT
SCHEMBL844980 0.86 ALDH1A1 (0.45) ALDH1A1CYP2C9CYP2C19POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed